Clinical trial · no report yet · Phase 1/Phase 2
LuTectomy
Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy
- NCT04430192 ↗
- Active not recruiting
- Peter MacCallum Cancer Centre, Australia
- 33 commentary sources found
- Standard
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Commentary we found
Podcasts, YouTube videos and X posts in our index that name this trial. A report screens them, searches for more and cites what clinicians said when it is built.
| Channel | Found | |
|---|---|---|
| X threads | 23 | |
| YouTube | 9 | |
| Podcasts | 1 |
The trial
ClinicalTrials.gov- Official title
- Study of the Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Radionuclide Therapy Prior to Radical Prostatectomy in Men With High-risk Localised Prostate Cancer
- Phase
- Phase 1/Phase 2
- Status
- Active not recruiting
- Conditions
- Prostatic Neoplasms
- Interventions
- 177Lu-PSMA-617
- Arms
- 177Lu-PSMA-617 followed by prostatectomy · Experimental
- Enrollment
- 20 (estimated)
- Primary outcomes
- To determine the radiation absorbed dose in the prostate and involved lymph nodes following one or two administrations of Lu-PSMA in men with HRCaP prior to radical prostatectomy
- Sponsor
- Peter MacCallum Cancer Centre, Australia with Movember Foundation, Medical Research Future Fund, Endocyte, E.J. Whitten Foundation Prostate Cancer Research Centre
- Start
- Aug 6, 2020
- Primary completion
- Dec 22, 2022
- Results posted
- No
- Registry record
- NCT04430192 · updated Nov 8, 2024
Publications
linked from the registry- Eapen RS, Buteau JP, Jackson P, Mitchell C, Oon SF, Alghazo O, McIntosh L, Dhiantravan N, Scalzo MJ, O'Brien J, Sandhu S, Azad AA, Williams SG, Sharma G, Haskali MB, Bressel M, Chen K, Jenjitranant P, McVey A, Moon D, Lawrentschuk N, Neeson PJ, Murphy DG, Hofman MS. Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study. Eur Urol. 2024 Mar;85(3):217-226. doi: 10.1016/j.eururo.2023.08.026. Epub 2023 Oct 26. PubMed 37891072